Advances in Endometrial Cancer Therapy: Exploring the Role of Immunotherapy

Download this slideset covering the most recent data on the use of immune checkpoint inhibitors for patients with advanced endometrial cancer.

This slideset is intended for clinicians practicing medicine outside of the United States.

Ana Oaknin, MD, PhD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.20 MB
Released: December 22, 2020

Acknowledgements

Supported by an educational grant from
GlaxoSmithKline

Related Content

Expert slides on biologic principles, indications, and clinical biomarkers for immune checkpoint inhibitors, from Clinical Care Options (CCO)

Sandip P. Patel, MD Released: April 16, 2021

Expert slides on multidisciplinary management of immune-related adverse events associated with checkpoint inhibitors, from Clinical Care Options (CCO)

Marianne Davies, DNP, CNS, ACNP-BC, AOCNP Released: April 16, 2021

Clinical Care Options (CCO) on-demand video featuring expert perspectives on using cytokine therapy for melanoma

Ahmad Tarhini, MD, PhD
Program Director
person default George Ebanks, RN, BSN, OCN person default Jennifer Swank, PharmD, BCOP
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: April 8, 2021 Expired: April 7, 2022

Downloadable slideset updated with highlights of key gynecologic oncology studies presented at conferences throughout 2021, from Clinical Care Options (CCO)

Jubilee Brown, MD Ursula Matulonis, MD Released: April 8, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue